Prophylactic use of anti-emetic medications reduced nausea and vomiting associated with exenatide treatment: a retrospective analysis of an open-label, parallel-group, single-dose study in healthy subjects.
about
The utility of animal models to evaluate novel anti-obesity agents.Safety and tolerability of exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trialsOptimizing the Care of Patients With Type 2 Diabetes Using Incretin-Based Therapy: Focus on GLP-1 Receptor Agonists.Comparison of safety and tolerability with continuous (exenatide once weekly) or intermittent (exenatide twice daily) GLP-1 receptor agonism in patients with type 2 diabetes.The use of non-insulin anti-diabetic agents to improve glycemia without hypoglycemia in the hospital setting: focus on incretins.Evidence-based practice use of incretin-based therapy in the natural history of diabetes.Practical implementation of incretin-based therapy in hospitalized patients with type 2 diabetes.Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?: The time has come for GLP-1 receptor agonists!MEDI0382, a GLP-1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single-dose, healthy-subject, randomized, Phase 1 study
P2860
Q35589958-E5FD6396-817A-40A8-B364-AF024F48CB73Q35780935-515E1E89-566F-4FC7-8EFE-58ACAA9C4BBFQ35906506-9A776451-4E48-4B4B-9DAD-7DCB68DD411EQ36498695-7FA0AEA4-8E3C-4A04-9D04-0AEC657B77B2Q38187004-E1DCF1D3-6CC9-4AF1-9A18-64AED0B76885Q38219482-B455BF6B-2682-4FB5-932A-E51FA69C4E37Q38303079-0E8236EB-3E9A-4D2D-B26A-A188CE8F2B22Q41886708-806F972D-BE0F-4E2B-A7F0-D50D09DC4828Q56967870-48A3EACD-CD3E-45D1-B671-BA764B0EF479
P2860
Prophylactic use of anti-emetic medications reduced nausea and vomiting associated with exenatide treatment: a retrospective analysis of an open-label, parallel-group, single-dose study in healthy subjects.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prophylactic use of anti-emeti ...... ose study in healthy subjects.
@ast
Prophylactic use of anti-emeti ...... ose study in healthy subjects.
@en
Prophylactic use of anti-emeti ...... ose study in healthy subjects.
@nl
type
label
Prophylactic use of anti-emeti ...... ose study in healthy subjects.
@ast
Prophylactic use of anti-emeti ...... ose study in healthy subjects.
@en
Prophylactic use of anti-emeti ...... ose study in healthy subjects.
@nl
prefLabel
Prophylactic use of anti-emeti ...... ose study in healthy subjects.
@ast
Prophylactic use of anti-emeti ...... ose study in healthy subjects.
@en
Prophylactic use of anti-emeti ...... ose study in healthy subjects.
@nl
P2093
P2860
P1433
P1476
Prophylactic use of anti-emeti ...... ose study in healthy subjects.
@en
P2093
B B Cirincione
I Yushmanova
M B Deyoung
P W Anderson
P2860
P304
P356
10.1111/J.1464-5491.2010.03085.X
P577
2010-10-01T00:00:00Z